Changes of circulating antibody levels induced by ABO antibody adsorption for ABO-incompatible kidney transplantation

American Journal of Transplantation

Volumn 9, Issue 5, 2009, Pages 1072-1080

  Valli, P V ^a   Yung, G Puga ^a,b   Fehr, T ^a   Schulz Huotari, C ^c   Kaup, N ^c   Gungor T ^d   Ambuhl P ^a   Weber, M ^a   Schanz, U ^a   Seebach, J D ^a,b   Stussi, G ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b University Hospital and Medical Faculty ^*  (Switzerland)

^c UNIVERSITY OF FREIBURG   (Germany)

^d UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

ABO blood group; ABO incompatible kidney transplantation; Flow cytometry; Immunoadsorption

Indexed keywords

ANTIGEN; CARBOHYDRATE; DIPHTHERIA ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PROTEIN ANTIBODY; RITUXIMAB; TETANUS ANTIBODY;

ADULT; AGGLUTINATION TEST; ALPORT SYNDROME; ANALGESIC NEPHROPATHY; ANTIBODY BLOOD LEVEL; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP ABO SYSTEM; CIRCULATION; CLINICAL ARTICLE; CLINICAL PRACTICE; CONCENTRATION (PARAMETERS); DIABETIC NEPHROPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GLOMERULONEPHRITIS; GRAFT REJECTION; HAEMOPHILUS; HUMAN; IMMUNOADSORPTION; KIDNEY HYPOPLASIA; KIDNEY INJURY; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; MALE; NEPHELOMETRY; PRIORITY JOURNAL; SINGLE DRUG DOSE; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

ABO BLOOD-GROUP SYSTEM; ADULT; BLOOD GROUP INCOMPATIBILITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEMAGGLUTINATION TESTS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 65249121428     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02579.x     Document Type: Article

References (36)

1. Tyden G, Donauer J, Wadstrom J et al. Implementation of a protocol for ABO-incompatible kidney transplantation - a three-center experience with 60 consecutive transplantations. Transplantation 2007 83 : 1153 1155.
2. Takahashi K, Saito K. Present status of ABO-incompatible kidney transplantation in Japan. Xenotransplantation 2006 13 : 118 122.
3. Milland J, Sandrin MS. ABO blood group and related antigens, natural antibodies and transplantation. Tissue Antigens 2006 68 : 459 466.
4. Ishida H, Tanabe K, Toma H, Akiba T. Therapeutic apheresis therapy for ABO-incompatible renal transplantations. Ther Apher Dial 2003 7 : 520 528.
5. Rahman T, Harper L. Plasmapheresis in nephrology: An update. Curr Opin Nephrol Hypertens 2006 15 : 603 609.
6. Tanabe K, Tokumoto T, Ishikawa N et al. ABO-incompatible living donor kidney transplantation under tacrolimus immunosuppression. Transplant Proc 2000 32 : 1711 1713.
7. Wilpert J, Geyer M, Pisarski P et al. On-demand strategy as an alternative to conventionally scheduled post-transplant immunoadsorptions after ABO-incompatible kidney transplantation. Nephrol Dial Transplant 2007 22 : 3048 3051.
8. Tyden G. The European experience. Transplantation 2007 84 (12 Suppl S2 S3.
9. Donauer J, Wilpert J, Geyer M et al. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: A single center experience. Xenotransplantation 2006 13 : 108 110.
10. Tyden G, Kumlien G, Genberg H, Sandberg J, Lundgren T, Fehrman I. ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab. Am J Transplant 2005 5 : 145 148.
11. Genberg H, Kumlien G, Wennberg L, Tyden G. Long-term results of ABO-incompatible kidney transplantation with antigen-specific immunoadsorption and rituximab. Transplantation 2007 84 (12 Suppl S44 S47.
12. Genberg H, Kumlien G, Wennberg L, Berg U, Tyden G. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: A 3-year follow-up. Transplantation 2008 85 : 1745 1754.
13. Kumlien G, Ullstrom L, Losvall A, Persson LG, Tyden G. Clinical experience with a new apheresis filter that specifically depletes ABO blood group antibodies. Transfusion 2006 46 : 1568 1575.
14. Norden G, Briggs D, Cockwell P et al. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment. Xenotransplantation 2006 13 : 148 153.
15. Rydberg L, Bengtsson A, Samuelsson O, Nilsson K, Breimer ME. In vitro assessment of a new ABO immunosorbent with synthetic carbohydrates attached to sepharose. Transpl Int 2005 17 : 666 672.
16. Zhou ZH, Tzioufas AG, Notkins AL. Properties and function of polyreactive antibodies and polyreactive antigen-binding B cells. J Autoimmun 2007 29 : 219 228.
17. Yung GP, Valli PV, Starke A et al. Flow cytometric measurement of ABO antibodies in ABO-incompatible living donor kidney transplantation. Transplantation 2007 84 (12 Suppl S20 S23.
18. Stussi G, Huggel K, Lutz HU, Schanz U, Rieben R, Seebach JD. Isotype-specific detection of ABO blood group antibodies using a novel flow cytometric method. Br J Haematol 2005 130 : 954 963.
19. Galili U, Anaraki F, Thall A, Hill-Black C, Radic M. One percent of human circulating B lymphocytes are capable of producing the natural anti-Gal antibody. Blood 1993 82 : 2485 2493.
20. Galili U, Rachmilewitz EA, Peleg A, Flechner I. A unique natural human IgG antibody with anti-alpha-galactosyl specificity. J Exp Med 1984 160 : 1519 1531.
21. Jordan SC, Vo AA, Peng A, Toyoda M, Tyan D. Intravenous gammaglobulin (IVIG): A novel approach to improve transplant rates and outcomes in highly HLA-sensitized patients. Am J Transplant 2006 6 : 459 466.
22. Wilpert J, Geyer M, Teschner S et al. ABO-incompatible kidney transplantation-proposal of an intensified apheresis strategy for patients with high initial isoagglutinine titers. J Clin Apheresis 2007 22 : 314 322.
23. Galili U. Xenotransplantation and ABO incompatible transplantation: The similarities they share. Transfus Apher Sci 2006 35 : 45 58.
24. Contreras M, Armitage SE, Hewitt PE. Response to immunization with A and B human glycoproteins for the procurement of blood grouping reagents. Vox Sang 1984 47 : 224 235.
25. Holburn AM. Radioimmunoassay studies of the cross-reacting antibody of human group O sera. Br J Haematol 1976 32 : 589 599.
26. Galili U, Ishida H, Tanabe K, Toma H. Anti-gal A/B, a novel anti-blood group antibody identified in recipients of abo-incompatible kidney allografts. Transplantation 2002 74 : 1574 1580.
27. McMorrow IM, Comrack CA, Nazarey PP, Sachs DH, DerSimonian H. Relationship between ABO blood group and levels of Gal alpha,3Galactose-reactive human immunoglobulin G. Transplantation 1997 64 : 546 549.
28. Zhou ZH, Zhang Y, Hu YF, Wahl LM, Cisar JO, Notkins AL. The broad antibacterial activity of the natural antibody repertoire is due to polyreactive antibodies. Cell Host Microbe 2007 1 : 51 61.
29. Kumlien G, Wilpert J, Safwenberg J, Tyden G. Comparing the tube and gel techniques for ABO antibody titration, as performed in three European centers. Transplantation 2007 84 (12 Suppl S17 S19.
30. Tanabe K. Interinstitutional variation in the measurement of anti-A/B antibodies: The Japanese ABO-Incompatible Transplantation Committee survey. Transplantation 2007 84 (12 Suppl S13 S16.
31. Rieben R, Korchagina EY, Bovin NV, Daha MR. Specificity of monoclonal antibodies against ABH and related structures tested by ELISA with synthetic glycoconjugates. Transfus Clin Biol 1997 4 : 47 54.
32. Krishnan NS, Fleetwood P, Higgins RM et al. Application of flow cytometry to monitor antibody levels in ABO incompatible kidney transplantation. Transplantation 2008 86 : 474 477.
33. Ephrem A, Misra N, Hassan G et al. Immunomodulation of autoimmune and inflammatory diseases with intravenous immunoglobulin. Clin Exp Med 2005 5 : 135 140.
34. Tanabe K, Takahashi K, Sonda K et al. Long-term results of ABO-incompatible living kidney transplantation: A single-center experience. Transplantation 1998 65 : 224 228.
35. Ferraro AJ, Drayson MT, Savage CO, MacLennan IC. Levels of autoantibodies, unlike antibodies to all extrinsic antigen groups, fall following B cell depletion with Rituximab. Eur J Immunol 2008 38 : 292 298.
36. Genberg H, Hansson A, Wernerson A, Wennberg L, Tyden G. Pharmacodynamics of rituximab in kidney allotransplantation. Am J Transplant 2006 6 : 2418 2428.